ORGANOGENESIS HOLDINGS INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
ORGANOGENESIS HOLDINGS INC. (ORGO) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $1.41 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2024-11-12
- 2024-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.41M.
- 2024-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.81M.
- 2024-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $4.22M.
- 2019-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2024-09-30 | $1.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.81M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.22M 10-Q · filed 2024-05-09 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |